Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses

Journal of Applied Physiology

Volumn 97, Issue 6, 2004, Pages 2214-2219

  Riechman, Steven E ^a,c   Balasekaran, G ^a   Roth, Stephen M ^b   Ferrell, Robert E ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

IL 15; Muscle quality; Skeletal muscle; Strength

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CYTOKINE PRODUCTION; EXERCISE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOASSAY; MALE; MULTIPLE REGRESSION; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE STRENGTH; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE;

ADULT; EXERCISE; FEMALE; HAPLOTYPES; HUMANS; INTERLEUKIN-15; MALE; MUSCLE, SKELETAL; PHENOTYPE; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; VARIATION (GENETICS);

EID: 9244242571     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00491.2004     Document Type: Article

References (29)

1. Abecasis GR and Cookson WO. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16: 182-183, 2000.
2. Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Shapiro DN, Morris SW, Park LS, and Cosman D. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 270: 29862-29869, 1995.
3. Angiolillo A, Kanegane H, Sgadari C, Reaman GH, and Tosato G. Interleukin-15 promotes angiogenesis in vivo. Biochem Biophys Res Commun 233: 231-237, 1997.
4. Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R, and Krause H. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain. FASEB J 13: 1575-1585, 1999.
5. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Ruckert R, Krause H, and Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 3: 1124-1128, 1997.
6. Carbó N, Lopez-Soriano J, Costelli P, Busquets S, Alverez B, Baccino FM, Quinn LS, Lopez-Soriano FJ, and Argiles JM. Interleukin-15 antagonizes muscle protein waste in tumor-bearing rats. Br J Cancer 83: 526-531, 2000.
7. Coletti D, Yang E, Marazzi G, and Sassoon D. TNFα inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J 21: 631-642, 2002.
8. Collins RA and Grounds MD. The role of tumor necrosis factor-alpha (TNF-α) in skeletal muscle regeneration. Studies in TNF-α(-/-) and TNF-α(-/-)/LT-α(-/-) mice. J Histochem Cyiochem 49: 989-1001, 2001.
9. Dubois S, Magrangeas F, Lehours P, Raher S, Bernard J, Boisteau O, Leroy S, Minvielle S, Godard A, and Jacques Y. Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem 274: 26978-26984, 1999.
10. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, and Cosman D. IL-15, a novel T-cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol 57: 763-766, 1995.
11. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, and Giri JG. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264: 965-968, 1994.
12. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, and Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans. FASEB J 15: 475-482, 2001.
13. Horsley V, Jansen KM, Mills ST, and Pavlath GK. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113: 483-494, 2003.
14. Miller SA, Dykes DD, and Pulesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
15. Nieman DC, Davis JM, Henson DA, Walberg-Rankin J, Shute M, Dunike CL, Utter AC, Vinci DM, Carson JA, Brown A, Lee WJ, McAnulty SR, and McAnulty LS. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol 94: 1917-1925, 2003.
16. Quinn LS, Anderson BG, Drivdahl RH, Alvarez B, and Argiles JM. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res 280: 55-63, 2002.
17. Quinn LS, Haugk KL, and Damon SE. Interleukin-15 stimulates C2 skeletal myoblast differentiation. Biochem Biophys Res Commun 239: 6-10, 1997.
18. Quinn LS, Haugk KL, and Grabstein KH. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 136: 3669-3672, 1995.
19. Riechman SE, Fabian TJ, Kroboth PD, and Ferrell RE. Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET. Physiol Genomics 17: 300-306, 2004.
20. Seltman H, Roeder K, and Devlin B. Evolutionary-based association analysis using haplotype data. Genet Epidemiol 25: 48-58, 2003.
21. Siri WE. Body composition from fluid spaces and density; analysis of methods. In: Techniques for Measuring Body Composition, edited by Brozek J and Henschel A. Washington, DC: Natl. Acad. Sci., 1961, p. 223-244.
22. Stegall T and Krolick KA. Myocytes respond to both interleukin-4 and interferon-gamma: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis. Clin Immunol 94: 133-139, 2000.
23. Sugiura T, Kawaguchi Y, Harigai M, Takagi K, Ohta S, Fukasawa C, Kara M, and Kamatani N. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production. J Immunol 164: 6593-6600, 2000.
24. Tagaya Y, Kurys G, Thies T, Losi JM, Azimi N, Hanover JA, Bamford RN, and Waldmann TA. Generation of secretable and non-secretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci USA 94: 14444-14449, 1997.
25. Tateyama M, Nagano I, Yoshioka M, Chida K, Nakamura S, and Itoyama Y. Expression of tumor necrosis factor-α in muscles in polymyositis. J Neurol Sci 146: 45, 1997.
26. Tisdale MJ. Loss of skeletal muscle in cancer: biochemical mechanisms. Front Biosci 6: D164-D174, 2001.
27. Vierck J, O'Reilly B, Hossner K, Antonio J, Byrne K, Bucci L, and Dodson M. Satellite cell regulation following myotrauma caused by resistance exercise. Cell Biol Int 24: 263-272, 2000.
28. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, and Harris TB. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57: M326-M332, 2002.
29. Wallach D. Cell death induction by TNF: a matter of self control. Trends Biochem Sci 22: 107-109, 1997.